ANI Pharmaceuticals
ANIP
71.93
+0.41
+0.57%
ANI Pharmaceuticals
US · ANIP
#2919 by market cap
Listed 1970
71.93
+0.41
+0.57%
Live - 5344 symbols - heartbeat 564s ago
· 2026-10-08 08:07
Pre-market
71.99
+0.08%
After-hours
72.15
+0.31%
- Market cap
- 1.65B
- P/E (TTM)i
- 15.67
- P/Bi
- 2.77
- EPSi
- 3.32
- Div yieldi
- 0.00%
- 52W posi
- 9%
Reader sentiment
Are you bullish or bearish on ANIP?
Anonymous reader poll. Unscientific, not investment advice.
About ANI Pharmaceuticals
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
- Founded
- 1996
- CEO
- Mr. Nikhil Lalwani
- Employees
- 970
- Headquarters
- Baudette, Minnesota, United States of America
- Fiscal year end
- 12-31
- Website
- anipharmaceuticals.com
Company profile
- Exchange
- US
- Symbol
- ANIP
- Market-cap rank
- #2919
- Listing date
- 1970-01-01
- Market cap
- 1.65B
- Float cap
- 1.52B
- Shares out
- 22.96M
- Float shares
- 21.19M
Sectors & themes
Quote time 2026-10-08 08:07:21 · For reference only, not investment advice and not tailored to your situation.